Proteome analysis of metastatic colorectal cancer cells recognized by the lectin Helix pomatia agglutinin (HPA)

Proteomics

Volumn 7, Issue 22, 2007, Pages 4082-4089

  Saint Guirons, Julien ^a   Zeqiraj, Elton ^a   Schumacher, Udo ^b   Greenwell, Pamela ^a   Dwek, Miriam ^a  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cancer; Glycoproteome; HPA; Lectin; Metastatic

Indexed keywords

ACTIN; AGGLUTININ; ALPHA TUBULIN; ALPHA6 INTEGRIN; BETA TUBULIN; CD51 ANTIGEN; CELL CYCLE PROTEIN 37; CELL MEMBRANE PROTEIN; CYTOKERATIN 18; CYTOKERATIN 8; GLYCOPROTEIN; HEAT SHOCK PROTEIN 70; LECTIN; LIPOCORTIN 2; LIPOCORTIN 4; N ACETYLGALACTOSAMINE; N ACETYLGLUCOSAMINE; PROTEIN TRAP 1; PROTEIN TUMOR REJECTION FACTOR 1; SIALIC ACID; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; CANCER CELL; COLORECTAL CANCER; HELIX POMATIA; HUMAN; HUMAN CELL; MASS SPECTROMETRY; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEOMICS; WESTERN BLOTTING;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; LECTINS; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; N-ACETYLGALACTOSAMINYLTRANSFERASES; N-ACETYLGLUCOSAMINYLTRANSFERASES; N-ACETYLNEURAMINIC ACID; PROGNOSIS; PROTEIN BINDING; PROTEOMICS; SENSITIVITY AND SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

HELIX POMATIA;

EID: 36549016590     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700434     Document Type: Article

References (26)

1. Dwek, M. V., Brooks, S. A., Harnessing changes in cellular glycosylation in new cancer treatment strategies. Curr. Cancer Drug Targets 2004, 4, 425-442.
2. Leathem, A. J., Brooks, S. A., Predictive value of lectin binding on breast-cancer recurrence and survival. Lancet 1987, 1, 1054-1056.
3. Brooks, S., The involvement of Helix pomatia lectin (HPA) binding N acetylgalactosamine glycans in cancer progression. Histol. Histopathol. 2000, 15, 143-158.
4. Brooks, S., Leathem, A., Expression of N-acetyl galactosaminylated and sialylated glycans by metastases arising from primary breast cancer. Invasion Metastasis 1998-1999, 18, 115-121.
5. Schumacher, U., Brooks, S., Mester, J., The lectin Helix pomatia agglutinin as a marker of metastases - clinical and experimental studies. Anticancer Res. 2005, 25, 1829-1830.
6. Brooks, S. A., Leathem, A. J. C., Altered expression of alpha-GalNAc glycoproteins by breast cancers. Br. J. Cancer 1995, 71, 1033-1038.
7. Dwek, M. V., Ross, H. A., Streets, A. J., Brooks, S. A. et al. Helix pomatia agglutinin lectin-binding oligosaccharides of aggressive breast cancer. Int. J. Cancer 2001, 95, 79-85.
8. Fenlon, S. et al., Helix pomatia and Ulex europeus lectin binding in human breast carcinoma. J. Pathol. 1987, 152, 169-176.
9. Chen, Y. et al., Use of sialylated or sulfated derivatives and acrylamide copolymers of Gal beta 1, 3 GalNAc alpha- and GalNAc alpha- to determine the specificities of blood group T- and Tn-specific lectins and the copolymers to measure anti-T and anti-Tn antibody levels in cancer patients. Glycoconj. J. 1995, 12, 55-62.
10. Piller, V., Piller, F., Cartron, J., Comparison of the carbohydrate-binding specificities of seven N-acetyl-D-galactosamine-recognizing lectins. Eur. J. Biochem. 1990, 191, 461-466.
11. Lehner, I., Niehof, M., Borlak, J., An optimized method for the isolation and identification of membrane proteins. Electrophoresis 2003, 24, 1795-1808.
12. Brooks, S. Wilkinson, D., Validation of a simple avidin-biotin detection method for Helix pomatia lectin (HPA) binding as a prognostic marker in cancer. Acta Histochem. 2003, 105, 205-212.
13. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680.
14. Gorg, A. et al., Recent developments in two-dimensional gel electrophoresis with immobilized pH gradients: Wide pH gradients up to pH 12, longer separation distances and simplified procedures. Electrophoresis 1999, 20, 712-717.
15. Pappin, D., Hojrup, P., Bleasby, A., Rapid identification of proteins by peptide mass fingerprinting. Curr. Biol. 1993, 3, 327-332.
16. Schumacher, U., Adam, E., Lectin histochemical HPA-binding pattern of human breast and colon cancers is associated with metastases formation in severe combined immunodeficient mice. Histochem. J. 1997, 29, 677-684.
17. Fountoulakis, M., Juranville, J., Manneberg, M., Comparison of the CBB, bicinchoninic and Lowry quantitation assays, using non-glycosylated and glycosylated proteins. J. Biochem. Biophys. Methods 1992, 24, 265-274.
18. Banks, R. E et al., Use of a sensitive EnVision +-based detection system for Western blotting: Avoidance of streptavidin binding to endogenous biotin and biotin-containing proteins in kidney and other tissues. Proteomics 1993, 3, 558-561
19. Valentiner, U. et al., HPA binding and metastasis formation of human breast cancer cell lines transplanted into severe combined immunodeficient (scid) mice. Cancer Lett. 2005, 219, 233-242.
20. Juliano, R. L., Varner, J. A., Adhesion molecules in cancer: The role of integrins. Curr. Opin. Cell Biol. 1983, 5, 812-818.
21. Prasad, S. et al., Intermediate filament proteins during carcinogenesis and apoptosis (review). Int. J. Oncol. 1999, 14, 563-570.
22. Ciocca, D., Calderwood, S., Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005, 10, 86-103.
23. Guinez, C., Lemoine, J., Michalski, J. C., Lefebvre, T., 70-kDa-heat shock protein presents an adjustable lectinic activity towards O-linked N-acetylglucosamine. Biochem. Biophys. Res. Commun. 2004, 319, 21-26.
24. Sgantzos M. N et al., Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors. Pathol. Res. Pract. 2007, 203, 31-37.
25. Walgren J. L., et al., High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin. Am. J. Physiol. Endocrinol. Metab. 2003, 284, E424-E434
26. Prokopishyn, N. et al., Integrin alpha3beta1 expressed by human colon cancer cells is a mahjor carrier of oncodevelopmental carbohydrate epitopes. J. Cell. Biochem. 1999, 72, 189-209.